Literature DB >> 21285422

Carriage of reduced-function CYP2C19 allele among patients treated with clopidogrel.

Ruben L J Osnabrugge, A Pieter Kappetein, A Cecile J W Janssens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21285422     DOI： 10.1001/jama.2011.77

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

Review 1.  A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users.

Authors:  Ruben L Osnabrugge; Stuart J Head; Felix Zijlstra; Jurriën M ten Berg; Myriam G Hunink; A Pieter Kappetein; A Cecile J W Janssens
Journal:  Genet Med       Date:  2014-06-19       Impact factor: 8.822

2.  Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection.

Authors:  Amber L Beitelshees; James M Stevenson; Nihal El Rouby; Chrisly Dillon; Philip E Empey; Elliot M Fielstein; Julie A Johnson; Nita A Limdi; Henry H Ong; Francesco Franchi; Dominick J Angiolillo; Joshua F Peterson; Marc B Rosenman; Todd C Skaar; Sony Tuteja; Larisa H Cavallari
Journal:  Genet Med       Date:  2020-07-17       Impact factor: 8.864
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.